News Releases Year None202120202019 Jun 01, 2021 Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter and Fiscal Year Ended March 31, 2021 Feb 16, 2021 Immunovant Reports Financial Results for the Quarter and Nine Months Ended December 31, 2020 Feb 02, 2021 Immunovant Announces Voluntary Pause in Clinical Dosing of IMVT-1401 Jan 12, 2021 Immunovant Appoints Rita Jain Chief Medical Officer And Provides Corporate Update
Jun 01, 2021 Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter and Fiscal Year Ended March 31, 2021
Feb 16, 2021 Immunovant Reports Financial Results for the Quarter and Nine Months Ended December 31, 2020
